Actavia Life Sciences Inc's ROI from its second quarter of 2024 to the second quarter of 2023 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Actavia Life Sciences Inc's ROI in the second quarter of 2024?
Due to the stockholders deficit and subsequent negative measured investments, it was not possible to calculate Actavia Life Sciences Inc 's return on investment (ROI) in its second quarter of 2024

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Mar 31 2024) II. Quarter	(Dec 31 2023) I. Quarter	(Sep 30 2023) IV. Quarter	(Jun 30 2023) III. Quarter	(Mar 31 2023) II. Quarter
Y / Y Investment Change TTM	-	-	-	-	-
Y / Y Net Income Change TTM	-	-	-	-	-
Investment (TTM) in Millions	-2	-2	-2	-2	-2
Return On Investment (TTM)	-	-	-	-	-
RASP's Overall Ranking	#	#	#	#	#
Seq. Investment Change TTM	-	-	-	-	-
Seq. Net Income Change TTM	-	-	-	-	-
Net Income (TTM) in Millions	0	-4	-4	-4	-5

RASP Company Profile >> Back to RASP Roi Comparisons >> See Annual RASP Return On Investment

Return On Investment RASP's Ranking
Within:	No.
Industry	#
Sector	#
Overall	#

Return On Investment Statistics
High	Average	Low
0 %	0 %	0 %

Financial Statements
Actavia Life Sciences Inc's II. Quarter Investments	$ -2 Millions	RASP's Balance sheet
Actavia Life Sciences Inc's II. Quarter Income	$ 0 Millions	Quarterly RASP's Income Statement
RASP's Income by Division		See RASP's Income by Division

RASP Annual Return On Investment	(Sep 30 2023) 2023	(Sep 30 2022) 2022	(Sep 30 2021) 2021	(Sep 30 2020) 2020	(Sep 30 2019) 2019
Total Investments in Millions	-2	-2	-3	-2	3
Y / Y Investment Growth	-	-	-	-	-18.48 %
Net Income in Millions	-4	-1	-1	-5	-1
Y / Y Net Income Growth	-	-	-	-	-
Annual Return On Investment	-	-	-	-	-36.86 %

Annual Roi Comment

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
RASP's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for RASP's Competitors
Subscribers only: Roi for Actavia Life Sciences Inc's Suppliers
Subscribers only: Return On Investment for RASP's Customers

Other Ratios
RASP's Roa	RASP's Inventory Turnover Ratio	RASP's Growth Rates	RASP's Dividend Statistics
	RASP's Profitability Ratios	RASP's Asset Turnover Ratio	RASP's Dividend Growth
RASP's Roe	RASP's Valuation Ratios	RASP's Financial Strength Ratios	RASP's Dividend Payout Ratio

Companies with similar Return On Investment at Mar 31 2024, within Healthcare Sector	ROI
Dariohealth Corp	52.42 %
Mimedx Group Inc	51.32 %
Siga Technologies Inc	50.83 %
Cardiff Lexington Corporation	43.02 %
Protagonist Therapeutics inc	42.60 %
Elite Pharmaceuticals Inc	41.12 %
Idexx Laboratories Inc	38.71 %
Medpace Holdings Inc	37.60 %
Nrc Health	34.98 %
Mettler toledo International Inc	34.94 %
Earth Science Tech Inc	34.92 %
Star Equity Holdings Inc	33.33 %
Interpace Biosciences Inc	33.18 %
Lantheus Holdings Inc	32.97 %
Lite Strategy Inc	32.16 %
Semler Scientific inc	30.36 %
Alaunos Therapeutics Inc	30.26 %
Johnson and Johnson	29.92 %
Cytomx Therapeutics Inc	28.98 %
Alkermes Plc	25.72 %
Sbc Medical Group Holdings Incorporated	24.59 %
Atlantic Coastal Acquisition Corp Ii	24.45 %
Arcutis Biotherapeutics Inc	24.32 %
Corcept Therapeutics Inc	23.79 %
Iradimed Corporation	23.45 %
Camp4 Therapeutics Corporation	22.66 %
Vertex Pharmaceuticals Inc	21.60 %
Kewaunee Scientific Corporation	21.33 %
Spero Therapeutics Inc	21.20 %
Harmony Biosciences Holdings inc	20.61 %

Date modified: 2026-09-08T15:11:16+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.